ApoA1
ApoA1 (apolipoprotein A1, also known as apolipoprotein A-I) is the major protein component of high density lipoprotein (HDL) in plasma. It takes part in the reverse transport of cholesterol from tissues to the liver and acts as a cofactor for LCAT. Browse Assay Genie's current range of ApoA1 research reagents below, or read on for the biology behind the target.
ApoA1 participates in the reverse transport of cholesterol from tissues to the liver for excretion. It does this by promoting cholesterol efflux from tissues and by acting as a cofactor for lecithin cholesterol acyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. As part of the SPAP complex, ApoA1 also activates spermatozoa motility.
The APOA1 gene encodes a preproprotein that is proteolytically processed to give the mature, secreted apolipoprotein A-I. It is the major protein component of high density lipoprotein (HDL) in plasma. Alternative splicing produces multiple transcript variants, at least one of which encodes a preproprotein. ApoA1 belongs to the apolipoprotein A1/A4/E family and sits in the HGNC apolipoproteins gene group. The gene is closely linked with two other apolipoprotein genes on chromosome 11, and the mouse and rat orthologs are both named Apoa1.
Defects in the ApoA1 gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. This makes ApoA1 a common subject in studies of HDL biology and cholesterol handling. Researchers measuring the ApoA1 protein or studying the ApoA1 gene often do so alongside related apolipoproteins.
ApoA1 is the major protein component of HDL in plasma, so it is a central subject in studies of lipoprotein structure and function.
ApoA1 promotes cholesterol efflux from tissues and carries cholesterol to the liver for excretion, making it key to this pathway.
As a cofactor for LCAT, ApoA1 supports the formation of most plasma cholesteryl esters, which is relevant to plasma lipid metabolism.
Defects in the ApoA1 gene are linked to HDL deficiencies such as Tangier disease and to systemic non-neuropathic amyloidosis.
ApoA1 promotes cholesterol efflux from tissues and returns cholesterol to the liver for excretion, a process called reverse cholesterol transport. It is also a cofactor for LCAT, which forms most plasma cholesteryl esters. As part of the SPAP complex, it activates spermatozoa motility.
The HGNC symbol is APOA1 and the approved name is apolipoprotein A1. The previous name, apolipoprotein A-I, is also the UniProt protein name. The gene encodes a preproprotein that is proteolytically processed into the mature protein, and alternative splicing yields multiple transcript variants.
Defects in the ApoA1 gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. Mouse and rat both have an ortholog named Apoa1. Check the datasheet of any product for its validated reactivity.
Other apolipoproteins from the same gene group, involved in lipoprotein metabolism and lipid transport.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P02647; product specifications from Assay Genie datasheets.